BBC presenter John Stapleton has revealed he has been diagnosed with Parkinson’s disease. The 78-year-old who is best known ...

Tuesday, Sept. 24, former Green Bay Packer and NFL Hall of Fame quarterback Brett Favre testified before Congress. Favre was ...

In the supplementary post-hoc analysis, treatment with solengepras 150 mg group reduced OFF time by -1.78 hours (p=?0.0045) compared to placebo and increased good ON time by +1.3 hours (p=0.04).

Parkinson's disease has been getting increased attention in the media, but misinformation abounds. Here, a Parkinson's expert ...

The FDA has just approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa).

The FDA on Thursday approved an injectable drug that eased Parkinson's disease symptoms and improved motor fluctuations in ...

Vyalev (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for motor ...

Vyalev is the first subcutaneous 24-hour continuous infusion of levodopa-based therapy for advanced Parkinson’s disease.

The chemical messenger dopamine is an essential catalyst that fuels activities and behaviors ranging from movement to ...

MeiraGTx Holdings’ MGTX clinical bridging study of its gene therapy candidate, AAV-GAD, for treating Parkinson’s disease (PD) ...